Join today
Improving Outcomes in Peripheral Bypass: The Role of TTFM & Imaging
Up to 20% of peripheral bypasses fail without a clear cause, and there's still no standard for completion control. While some hospitals use transit time flow measurement (TTFM) and high-frequency ultrasound imaging (HFUS), clinical documentation is limited.
In this course, you will hear from the lead investigator of the newly started international PATENT study, Professor Michael S. Conte. The PATENT study was designed to establish evidence-based protocols and reduce graft failure in CLTI patients. You’ll also gain real-world insights from seasoned vascular surgeon, Katariina Noronen, MD, using Medistim technology to improve outcomes in daily practice. Additionally, you'll hear from Cecilia Fenelli, MD regarding a clinical in-situ bypass case recently performed at the Azienda USL Toscana Centro in Florence, Italy.
In this course, you will hear from the lead investigator of the newly started international PATENT study, Professor Michael S. Conte. The PATENT study was designed to establish evidence-based protocols and reduce graft failure in CLTI patients. You’ll also gain real-world insights from seasoned vascular surgeon, Katariina Noronen, MD, using Medistim technology to improve outcomes in daily practice. Additionally, you'll hear from Cecilia Fenelli, MD regarding a clinical in-situ bypass case recently performed at the Azienda USL Toscana Centro in Florence, Italy.
Meet the instructor
Anne Waaler
Anne Waaler joined Medistim as VP Medical Department in 2016. Ms. Waaler holds a M.Sc. in Pharmacy from the University of Oslo, an MBA from the Norwegian School of Management (BI) in Oslo, and an ESCP-EAP in Paris. She has more than 25 years of experience from the pharma and medtech industry and has previously worked for Nycomed and GE Healthcare, where she held a variety of different roles within medical, marketing and strategy.
The content is based on clinical experience and published articles and is not intended
to be a substitute for medical advice, diagnosis or treatment. Each surgeon should exercise his or her own independent judgment in the diagnosis and treatment of the individual patient. Please refer to the Medistim Instructions for Use (IFU) for indications, contraindications, warnings, precautions, and further specifications and descriptions.
Copyright © Medistim 2024